A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever

Clinical trial NCT05480800 · COMPLETED

Trial details

NCT number: NCT05480800
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Salmonella Infections

Start date: 2022-09-13
Primary completion: 2024-09-02
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.